AtriCure Inc. said Wednesday it had reached a tentative $3.8 million settlement with the U.S. Department of Justice to lay to rest allegations over marketing practices related to the medical device maker's surgical ablation devices.
A federal court has granted joint motions to dismiss several qui tam suits filed by oil tycoon Jack Grynberg alleging anti-competitive practices on the part of several natural gas companies — including Exxon Co. USA, Enron Corp. and Mobil Natural Gas Inc. — in a multidistrict litigation over a decade old.
Nursing home pharmacy giant Omnicare Inc. has agreed to shell out $98 million and a Teva Pharmaceutical Industries Ltd. unit has agreed to pay $14 million to settle claims that they were part of a wide-scale kickback conspiracy.
The U.S. government has filed a False Claims Act lawsuit accusing a Canadian textile company of knowingly selling defective Zylon fabric to American body armor manufacturers for use in bulletproof vests.
A Texas subsidiary of Universal Health Services Inc. has agreed to fork over $27.5 million to settle the U.S. Department of Justice’s allegations it paid kickbacks to doctors who referred patients to its hospitals.
British drugmaker Shire PLC has received a subpoena from U.S. investigators seeking documents related to the sales and marketing of three drugs, including Adderall, the company said.
Defense contractor IIF Data Solutions is off the hook in a qui tam suit seeking $140 million in damages and alleging that IIF and its founder falsely obtained U.S. General Service Administration contracts by misrepresenting their commercial history, then falsely overcharged on those contracts.
AstraZeneca Pharmaceuticals LP has agreed to pay $520 million to settle an investigation by the U.S. Attorney's Office for the Eastern District of Pennsylvania into sales and marketing practices for the company's antipsychotic drug Seroquel.
The state of California slapped State Street Bank & Trust Co. with a $200 million qui tam lawsuit Tuesday over allegations the bank committed “unconscionable fraud” against two of the state's largest pension funds by overcharging for the costs of executing foreign currency trades since 2001.
Mylan Inc. and several other pharmaceutical companies will pay a combined sum of $124 million to settle allegations that they bilked state Medicaid programs of millions of dollars by improperly classifying certain drugs for rebate purposes.
The U.S. Supreme Court has already heard or is poised to hear five labor and employment cases this term, including two labor cases involving arbitration issues, a Title VII case with echoes of the controversial Ledbetter decision and a case over how much deference courts should give to Employee Retirement Income Security Act plan administrators.
AT&T Missouri has agreed to pay the U.S. Department of Justice $1.4 million in civil penalties as part of a settlement over allegations that the company engaged in noncompetitive bidding for Internet contracts at Kansas City, Mo., schools.
Cephalon Inc. has won dismissal of a putative class action brought by a group of municipal benefit funds over the pharmaceutical company's alleged efforts to market three drugs for uses that did not have regulatory approval.
Forest Laboratories Inc. has moved to settle a lawsuit brought by the U.S. Department of Justice and two whistleblowers accusing the company of bribing doctors to prescribe antidepressants Celexa and Lexapro and marketing the drugs for pediatric use without approval from the U.S. Food and Drug Administration.
A New York City hospital is seeking to dismiss allegations it engaged in massive Medicare fraud and should be fined more than $2 billion in a case brought against the hospital and its accounting firm by a former top-level executive at another nearby hospital.
The biggest mistake lawyers make when writing up a petition for a writ of certiorari is thinking of it as just another appeal, experts say. Here is a list of tips compiled by Law360 for filing a cert petition that is sure to pique the interest of U.S. Supreme Court justices.
Science Applications International Corp. will have to pay the U.S. government a $6.5 million judgment for misrepresenting business relationships in order to secure contracts and payment from the U.S. Nuclear Regulatory Commission after a federal judge denied the company's bid for a new trial and lifted a stay of execution Sept. 14.
Skadden Arps Slate Meagher & Flom LLP has bolstered its health care and life science practice with the addition of a former U.S. Food and Drug Administration official from King & Spalding LLP who has represented companies in complex product liability cases.
Ven-A-Care of the Florida Keys Inc. and Abbott Laboratories have traded motions for partial summary judgment in a whistleblower suit filed by Ven-A-Care accusing Abbott of reporting inflated prices for generic drugs containing the antibiotic erythromycin to Medicaid.
An appeals court has refused to resurrect a False Claims Act suit against companies including Sallie Mae Inc., ruling that the plaintiff's lawyer's conduct — which included consistently missed deadlines and a leak of confidential information to a reporter — was appropriately punished with a dismissal.